|
US5214170A
|
|
Radioisotope iodine-labeled 1α (or 24R), 25-dihydroxy vitamin D3
|
|
EP0482948A1
|
|
A medicament composition containing 6-substituted alkoxy quinoxaline derivative and its production
|
|
EP0477700A1
|
|
6'-C-alkyl- or alkynyl-neplanocin A, and its preparation process and use
|
|
US5162201A
|
|
Analytical method making use of monoglyceride lipase
|
|
JPH04211387A
|
|
Method for base exchange reaction with phospholipase d-p
|
|
JPH04210993A
|
|
New phospholipid-nucleoside derivative
|
|
JPH04210921A
|
|
Antitumor agent containing new phospholipid-nucleoside derivative as active component
|
|
JPH04237468A
|
|
Use of polymerized selenium-containing microbial cell
|
|
JPH04229177A
|
|
New plasmid
|
|
JPH04221388A
|
|
Cephalosporin compound and production thereof
|
|
JPH04183389A
|
|
Production of peroxidase
|
|
JPH03224498A
|
|
High sensitivity analysis of bile acid and composition therefor
|
|
JPH04179498A
|
|
Method and composition for determining l-malic acid or oxaloacetic acid in high sensitivity
|
|
JPH03251196A
|
|
Method and composition for measuring l-carnitine in high sensitivity
|
|
JPH04169179A
|
|
Production of stabilized spore-forming viable bacterium preparation
|
|
JPH04158799A
|
|
High-sensitivity determination of d-3-hydroxybutyric acid or acetoacetic acid and composition for determination
|
|
JPH04148698A
|
|
Method for measuring reverse transcriptase using hybridized substance of primer converted into solid phase and template rna
|
|
JPH04148697A
|
|
Method for measuring reverse transcriptase using primer converted into solid phase
|
|
JPH04148681A
|
|
Acylcarnitine esterase, its production and measurement of acylcarnitine
|
|
JPH04148687A
|
|
Stably highly manifestative recombinant vector for m-csf active polypeptide
|
